What is Xealth? Xealth is a clinical deployment and prescribing platform that enables health systems to deliver digital therapeutics, patient apps, and remote-care tools directly within clinical workflows. The platform centralizes formulary-like catalogs of vetted digital interventions and connects them to EHR workflows, clinician orderables, and patient messaging—turning software into a prescribable, trackable part of […]
Feature Categories
What is Xealth?
Xealth is a clinical deployment and prescribing platform that enables health systems to deliver digital therapeutics, patient apps, and remote-care tools directly within clinical workflows. The platform centralizes formulary-like catalogs of vetted digital interventions and connects them to EHR workflows, clinician orderables, and patient messaging—turning software into a prescribable, trackable part of care.
Use cases include post-discharge digital coaching, chronic disease self-management, behavioural health programs, and RPM-enabled interventions. Designed for hospitals, health systems, and payer-provider networks, Xealth focuses on operationalising DTx at scale by simplifying prescribing, tracking adherence, and measuring engagement and outcomes at the population level.
Why Leading Healthcare Teams Trust Xealth
- Functions as a HIPAA Business Associate with health systems, implementing administrative, physical, and technical security safeguards to protect protected health information with all data encrypted at rest
- Runs on AWS infrastructure and integrates with major EHR systems including Epic and Cerner
- Named to CB Insights Digital Health 150 and Fierce Healthcare's Fierce 15 in 2023
- Won Gold Award for Connected Digital Health in the Spring 2024 Digital Health Awards
- Works with over 30 large health systems and 500 hospitals, integrating more than 80 digital health solutions, with customers including Mass General Brigham, Duke Health, UPMC, and Advocate Health
- Raised funding from major healthcare investors including Novartis, Philips, ResMed, and McKesson Ventures
- Backed by 14 health systems as investors, demonstrating provider confidence in the platform
- Acquired by Samsung Electronics in 2025 to bridge wellness data from wearables with clinical decision-making, with the acquisition completed in October 2025
Top 3 Pain Points Xealth Fixes in Healthcare
| Problem | How Xealth Solves It |
|---|---|
| 1. Difficulty integrating digital therapeutics into clinical workflows | Embeds DTx prescribing directly into EHR orderables and clinician workflows, making digital therapies part of standard care. |
| 2. Low patient adoption and engagement with digital health tools | Provides a centralised, curated catalogue of approved digital interventions, tracks usage, and surfaces patients needing outreach to improve adherence. |
| 3. Limited visibility into outcomes and ROI from digital therapeutics | Aggregates engagement and outcomes data, enabling analytics for population health, value-based care, and decision-making on DTx efficacy and expansion. |
Feature Category Summary: Xealth
| Feature Category | Summary | Association (YES, NO, NA) |
|---|---|---|
| Regulatory-Ready | Xealth positions its platform as a secure integration layer that helps health systems centralize digital health solutions within the EHR and explicitly notes that it helps ensure integrated tools comply with regulations such as HIPAA and ONC interoperability rules, providing standardized, secure connections and consolidated oversight. This demonstrates support for regulated healthcare IT environments and audit-friendly aggregation of digital tools, but there is no indication that Xealth itself is an FDA/EMA‑cleared medical device or marketed as a validated GxP application. | NA |
| Clinical Trial Support | Xealth is consistently described as a digital health integration and activation platform enabling clinicians to prescribe and monitor apps, devices, and content from within the EHR, with use cases focused on routine care pathways, remote monitoring, and patient engagement rather than trial protocol design or data capture. No public documentation was found describing dedicated functionality for clinical trial design, feasibility, patient recruitment, investigational product management, or trial reporting. | NO |
| Supply Chain & Quality | Product materials highlight organizing and governing digital health programs, aggregating data, and simplifying integration of patient-facing tools, but do not reference pharmaceutical manufacturing execution, logistics, serialization, or counterfeit‑drug detection capabilities. No public documentation was found indicating modules for manufacturing integrity or physical supply‑chain QA. | NO |
| Efficiency & Cost-Saving | Xealth centralizes vendor integrations and digital health ordering into a single SMART on FHIR app inside the EHR to reduce clicks, consolidate dashboards, and avoid multiple logins, explicitly aiming to make life easier for clinicians and reduce IT burden through one set of integrations. Case materials and partner descriptions emphasize streamlined onboarding of digital tools, faster program launches, and improved operational efficiency, which reduce internal costs and staff time spent managing disparate digital solutions. | YES |
| Scalable / Enterprise-Grade | Xealth is described as enabling digital health “at scale” and is used by leading U.S. health systems, with Samsung’s acquisition announcement indicating expansion to more than 500 hospitals and integration with over 70 digital health solutions, reflecting large, enterprise deployments. The platform centralizes integration for many third‑party vendors and supports system‑wide governance and analytics, evidencing an enterprise‑grade architecture suitable for large provider organizations. | YES |
| HIPAA Compliant | Xealth describes itself and is described by partners as a secure health tech platform that handles PHI for leading health systems, and its security blog notes that the platform helps ensure that connected digital health integrations comply with regulations such as HIPAA via standardized secure connections. A Virtru case study further details that Xealth needed HIPAA‑compliant mechanisms for sharing PHI and implemented encrypted workflows to maintain HIPAA compliance during onboarding and support, reinforcing explicit HIPAA alignment. | YES |
| Clinically Validated | Xealth case studies (e.g., UPMC) show successful implementation of digital prescribing and remote monitoring workflows and suggest improvements in patient engagement and care outcomes, but they are operational/program evaluations rather than prospective clinical trials of Xealth as a therapeutic intervention. No public evidence was found of randomized or prospective clinical studies demonstrating outcome improvements directly attributable to the Xealth platform itself for a defined clinical indication. | NA |
| EHR Integration | Xealth’s core proposition is a SMART on FHIR digital care app that centralizes digital health tools and related data “within the EHR,” enabling clinicians to order, deliver, and monitor digital health solutions directly from their EHR workflow. Case studies and partner integrations (e.g., SeamlessMD, Artera) explicitly describe enrollment, status viewing, and monitoring occurring from within EHR dashboards via Xealth, confirming deep EHR integration as a primary feature. | YES |
| Explainable AI | Xealth references a “clinical AI engine” that helps organize digital tools and data within the EHR and drive activation and engagement, but available descriptions do not outline model interpretability features, feature‑importance views, or user‑facing explanations for AI‑driven recommendations. No public documentation was found that labels components as “explainable AI” or describes formal explainability mechanisms designed for regulatory transparency. | NA |
| Real-Time Analytics | The platform provides consolidated reporting and analytics on digital health utilization across patient populations and physician groups and supports viewing remote monitoring data and updated care plan status within the EHR, implying near‑real‑time visibility into patient engagement and device feeds as they are received. However, Xealth is not marketed as a generalized real‑time streaming analytics platform with explicit latency guarantees; its real‑time capabilities are tied to digital health program monitoring rather than broad, continuous analytics. | YES |
| Bias Detection | While Xealth’s resources discuss security, interoperability, and digital engagement strategy, there is no mention of tools to detect, quantify, or correct algorithmic bias across demographic or clinical sub‑cohorts in any AI components. No public documentation was found describing fairness metrics, bias dashboards, or bias‑monitoring workflows. | NO |
| Ethical Safeguards | Xealth emphasizes strong security, regulatory compliance (including HIPAA and ONC interoperability rules), and centralized governance over digital tools through a “digital command center,” giving health systems control over which tools are deployed and how data flows, which are important governance mechanisms. However, public materials do not describe explicit patient consent management features, configurable AI use‑case restrictions, or formal human‑in‑the‑loop approval flows beyond existing clinical workflows and institutional governance. | NA |
Risks & Limitations: Xealth
-
Program success depends on the clinical efficacy of the prescribed digital therapeutics; platform-level adoption cannot substitute for weak clinical outcomes.
-
Engagement and adherence to DTx vary widely; low patient uptake reduces impact.
-
Integration with proprietary EHRs and clinical workflows may require IT effort and change management.
-
Regulatory, privacy, and contractual considerations (vendor agreements, data sharing, reimbursement) must be managed for scaled deployments.
Tags
Share This AI Tool
Get a neutral, no obligation view of whether this AI tool fits your portfolio
Stephen
Founder of HealthyData.Science · 20+ years in life sciences compliance & software validation · MSc in Data Science & Artificial Intelligence.